Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Axelle Gilles, Sebastian Vermeersch, Pieter Vermeersch, Fleur Wolff, Frederic Cotton, Sebastien Tilleux & David Cassiman. (2022) Expert consensus statement on acute hepatic porphyria in Belgium. Acta Clinica Belgica 77:4, pages 735-741.
Read now
Read now
Andrea Ricci & Paolo Ventura. (2022) Givosiran for the treatment of acute hepatic porphyria. Expert Review of Clinical Pharmacology 15:4, pages 383-393.
Read now
Read now
Juliane Sachau, Dilara Kersebaum, Ralf Baron & Anthony H Dickenson. (2020) Unusual Pain Disorders – What Can Be Learned from Them?. Journal of Pain Research 13, pages 3539-3554.
Read now
Read now
Samira Massachi, Josh Epstein, Julie Hurd & Herbert L. Bonkovsky. (2020) Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP). Journal of Medical Economics 23:12, pages 1441-1449.
Read now
Read now
Barbara Blaylock, Josh Epstein & Paul Stickler. (2020) Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin. Journal of Medical Economics 23:6, pages 537-545.
Read now
Read now
Zachary Spiritos, Shakirat Salvador, Diana Mosquera & Julius Wilder. (2019) Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Therapeutics and Clinical Risk Management 15, pages 1443-1451.
Read now
Read now
Frid Sofie Lichtwarck Bjugn, Elin Storjord, Roy Morten Kristensen & Ole-Lars Brekke. (2019) Safe usage of bicalutamide and goserelin in a male patient with acute intermittent porphyria and prostate cancer. Scandinavian Journal of Urology 53:2-3, pages 171-173.
Read now
Read now
Loukas Kakoullis, Stylianos Louppides, Eleni Papachristodoulou & George Panos. (2018) Porphyrias and photosensitivity: pathophysiology for the clinician. Postgraduate Medicine 130:8, pages 673-686.
Read now
Read now
Rashmi Dhital, Sijan Basnet, Dilli Ram Poudel & Khema Raj Bhusal. (2017) Acute intermittent porphyria: a test of clinical acumen. Journal of Community Hospital Internal Medicine Perspectives 7:2, pages 100-102.
Read now
Read now
Delia D’Avola & Gloria Gonzalez Aseguinolaza. (2016) Prospect and progress of gene therapy in acute intermittent porphyria. Expert Opinion on Orphan Drugs 4:7, pages 711-717.
Read now
Read now
Articles from other publishers (105)
Ängla Mantel, Daphne Vassiliou, Mattias Lissing, Olof Stephansson, Staffan Wahlin & Eliane Sardh. (2023)
Maternal and fetal outcomes in acute hepatic porphyria:
A Swedish National Cohort S
tudy
. Journal of Inherited Metabolic Disease 46:4, pages 675-686.
Crossref
Crossref
Elena Pischik, Katrin Baumann, Alla Karpenko & Raili Kauppinen. (2023) Pathogenesis of acute encephalopathy in acute hepatic porphyria. Journal of Neurology 270:5, pages 2613-2630.
Crossref
Crossref
Esma Z Kizilaslan, Nitin M Ghadge, Andrea Martinez, Michelle Bass, Rahul Winayak, Midhun Mathew, Rutvi Amin, Muhammad Khan & Nadeem Kizilbash. (2023) Acute Intermittent Porphyria’s Symptoms and Management: A Narrative Review. Cureus.
Crossref
Crossref
Friedhelm Sayk & Lars Grasshoff. (2023) Akute hepatische PorphyrienAcute hepatic porphyrias. Medizinische Klinik - Intensivmedizin und Notfallmedizin 118:1, pages 21-29.
Crossref
Crossref
Salini Sreevalsakumar, Chandralekha Nair, Balachandar Vellingiri & Abilash Valsala Gopalakrishnan. 2020. Genetic Syndromes. Genetic Syndromes
1
4
.
Rochus Neeleman, Kyra Musters, Margreet Wagenmakers, Sophie Mijnhout, Edith Friesema, Eric Sijbrands & Janneke Langendonk. (2022) Mortality in Pedigrees with Acute Intermittent Porphyria. Life 12:12, pages 2059.
Crossref
Crossref
Matteo Marcacci, Andrea Ricci, Chiara Cuoghi, Stefano Marchini, Antonello Pietrangelo & Paolo Ventura. (2022) Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
A. Poli, C. Schmitt, T. Lefebvre, H. Puy & L. Gouya. (2022) Porfirias hereditarias en niños. EMC - Pediatría 57:4, pages 1-10.
Crossref
Crossref
Valeriia Dorofieieva & Olena Fedota. (2022) Large family genetic analysis: effects of variegated porphyria and hemophilia b on reproductive traits. The Journal of V. N. Karazin Kharkiv National University, Series "Medicine":45, pages 24-36.
Crossref
Crossref
Mohamed Kazamel, Elena Pischik & Robert J. Desnick. (2022) Pain in acute hepatic porphyrias: Updates on pathophysiology and management. Frontiers in Neurology 13.
Crossref
Crossref
David Cassiman, Raili Kauppinen, Susana Monroy, Ming‐Jen Lee, Herbert L. Bonkovsky, Manish Thapar, Encarna Guillén‐Navarro, Anna‐Elisabeth Minder, Cecilia Hale, Marianne T. Sweetser & Aneta Ivanova. (2022)
EXPLORE
B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms
. Journal of Inherited Metabolic Disease 45:6, pages 1163-1174.
Crossref
Crossref
Edwige Collaud, Luis Wittwer, Anna-Elisabeth Minder, Jean-Marie Annoni, Elisabeth I. Minder & Joelle N. Chabwine. (2022) Case Report: Variegate porphyria disclosed by post-gastric bypass complications and causing predominant painful sensorimotor axonal peripheral neuropathy. Frontiers in Genetics 13.
Crossref
Crossref
Kristen Wheeden, Desiree Lyon Howe, Sue Burrell, Liz Gill, John Chamberlayne, Edrin R. Williams, Amy Simon, John J. Ko, Jordanna Mora, Ted Wells, Christopher Evans, Maggie Paulich, Stephen Meninger & Stephen Lombardelli. (2022) Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts. Advances in Therapy 39:9, pages 4330-4345.
Crossref
Crossref
Bruce Wang, Paolo Ventura, Kei-ichiro Takase, Manish Thapar, David Cassiman, Ilja Kubisch, Shangbin Liu, Marianne T. Sweetser & Manisha Balwani. (2022) Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study. Orphanet Journal of Rare Diseases 17:1.
Crossref
Crossref
Elin Storjord, Stella Airila-Månsson, Katarzyna Karlsen, Martin Madsen, Jim André Dahl, Anne Landsem, Hilde Fure, Judith Krey Ludviksen, Johannes Østrem Fjøse, Amy K. Dickey, Bård Ove Karlsen, Erik Waage Nielsen, Tom Eirik Mollnes & Ole-Lars Brekke. (2022) Dental and Periodontal Health in Acute Intermittent Porphyria. Life 12:8, pages 1270.
Crossref
Crossref
Granata Francesca, Annamaria Nicolli, Alessia Colaiocco, Elena Di Pierro & Giovanna Graziadei. (2022) Psychological Aspect and Quality of Life in Porphyrias: A Review. Diagnostics 12:5, pages 1193.
Crossref
Crossref
Eliane Sardh & Pauline Harper. (2022) RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria. Journal of Internal Medicine 291:5, pages 593-610.
Crossref
Crossref
William R Hersh, Aaron M Cohen, Michelle M Nguyen, Katherine L Bensching & Thomas G Deloughery. (2022) Clinical study applying machine learning to detect a rare disease: results and lessons learned. JAMIA Open 5:2.
Crossref
Crossref
Miriam Longo, Erika Paolini, Marica Meroni & Paola Dongiovanni. (2022) Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. Biomedicines 10:3, pages 648.
Crossref
Crossref
Katrin Baumann & Raili Kauppinen. (2022) Long-term follow-up of acute porphyria in female patients: Update of clinical outcome and life expectancy. Molecular Genetics and Metabolism Reports 30, pages 100842.
Crossref
Crossref
Antoine Poli, Caroline Schmitt, Boualem Moulouel, Arienne Mirmiran, Neila Talbi, Sophie Rivière, Diane Cerutti, Isabelle Bouchoule, Anthony Faivre, Vincent Grobost, Claire Douillard, Francis Duchêne, Valeria Fiorentino, Thierry Dupré, Hana Manceau, Katell Peoc'h, Hervé Puy, Thibaud Lefebvre & Laurent Gouya. (2022) Givosiran in acute intermittent porphyria: A personalized medicine approach. Molecular Genetics and Metabolism 135:3, pages 206-214.
Crossref
Crossref
Cristina Sirch, Niloufar Khanna, Lynda Frassetto, Francesco Bianco & Mary Louise Artero. (2022) Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report. World Journal of Transplantation 12:1, pages 8-14.
Crossref
Crossref
M.F. Ivanova. (2022) Abdominal pain and other clinical and imaging features of porphyria. (Review. Own observations). Russian Journal of Pain 20:4, pages 52.
Crossref
Crossref
Smriti Rajita Kumar, Diana Byrnes, Mahmoud Mahfouz, Joseph Rosenblatt & Cynthia Levy. (2022) Time is of the Essence: Using Extended Hemin Treatment for a Case of Severe Acute Intermittent Porphyria. ACG Case Reports Journal 9:7, pages e00827.
Crossref
Crossref
Paolo Ventura, Herbert L. Bonkovsky, Laurent Gouya, Paula Aguilera‐Peiró, D. Montgomery Bissell, Penelope E. Stein, Manisha Balwani, D. Karl E. Anderson, Charles Parker, David J. Kuter, Susana Monroy, Jeeyoung Oh, Bruce Ritchie, John J. Ko, Zhaowei Hua, Marianne T. Sweetser & Eliane Sardh. (2021) Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study. Liver International 42:1, pages 161-172.
Crossref
Crossref
Karl E. Anderson, Robert J. Desnick, M. Felicity Stewart, Paolo Ventura & Herbert L. Bonkovsky. (2022) Acute Hepatic Porphyrias: “Purple Flags”—Clinical Features That Should Prompt Specific Diagnostic Testing. The American Journal of the Medical Sciences 363:1, pages 1-10.
Crossref
Crossref
Mark P. Connolly, Nikos Kotsopoulos, Sebastian Vermeersch, Julien Patris & David Cassiman. (2021) Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Daphne Vassiliou, Eliane Sardh, Pauline Harper, Amy R. Simon, Valerie A. Clausen, Nader Najafian, Gabriel J. Robbie & Sagar Agarwal. (2021) A Drug‐Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver. Clinical Pharmacology & Therapeutics 110:5, pages 1250-1260.
Crossref
Crossref
А. I. Puzikova, Е. А. Litvin, D. А. Kildyushkin & А. Е. Druy. (2021) Application of high-performance liquid chromatography in porphyrias diagnostics. Pediatric Hematology/Oncology and Immunopathology 20:3, pages 140-144.
Crossref
Crossref
Miriam Longo, Erika Paolini, Marica Meroni, Lorena Duca, Irene Motta, Anna Ludovica Fracanzani, Elena Di Pierro & Paola Dongiovanni. (2021) α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study. Diagnostics 11:9, pages 1628.
Crossref
Crossref
Karl E. Anderson, Raynah Lobo, Denise Salazar, Mary Schloetter, Gary Spitzer, Amy L. White, Randolph M. Young, Herbert L. Bonkovsky, Elizabeth L. Frank, Jordanna Mora & Silvia Tortorelli. (2021) Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians. The American Journal of the Medical Sciences 362:2, pages 113-121.
Crossref
Crossref
Renata Pająk, Ewelina Mendela, Natalia Będkowska & Justyna Paprocka. (2021) Update on Neuropathies in Inborn Errors of Metabolism. Brain Sciences 11:6, pages 763.
Crossref
Crossref
Tim Steinberg, Mustafa Kilic, Kornelius Fuchs, Karel Hanyk, Ralf A. Linker, Felix Schlachetzki & Bernhard Neumann. (2021) Case report of a complicated neurologically manifesting acute porphyria treated successfully with Givosiran. Journal of the Neurological Sciences 422, pages 117334.
Crossref
Crossref
Helene J. Bustad, Juha P. Kallio, Marta Vorland, Valeria Fiorentino, Sverre Sandberg, Caroline Schmitt, Aasne K. Aarsand & Aurora Martinez. (2021) Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators. International Journal of Molecular Sciences 22:2, pages 675.
Crossref
Crossref
Mario Alberto Quintero García & Andrea Martínez de la Vega Celorio. (2021) Manejo de dolor con lidocaína en crisis aguda de porfiria en urgencias. Anales Médicos de la Asociación Médica del Centro Médico ABC 66:3, pages 214-217.
Crossref
Crossref
Paulo Victor Sgobbi de Souza, Bruno de Mattos Lombardi Badia, Igor Braga Farias, Eduardo Augusto Gonçalves, Wladimir Bocca Vieira de Rezende Pinto & Acary Souza Bulle Oliveira. (2021) Acute hepatic porphyrias for the neurologist: current concepts and perspectives. Arquivos de Neuro-Psiquiatria 79:1, pages 68-80.
Crossref
Crossref
Margret Alm, Viola Andresen, Christian Ell, Christiane Fibbe, Wolfgang Fischbach, Jutta Keller, PH. Frank Kipp, Andrea May, Stephan Miehlke, Rainer Porschen, Andreas Stallmach, Thomas Weinke, Niklas Aehling, Margret Alm, Viola Andresen, Daniel C. Baumgart, Franziska Bertram, Albrecht Böhlig, Catharina Bullmann, Johanna Carstensen, Marie de Greck, Wienke Ellerbeck, Giulia Enders, Christiane Fibbe, Wolfgang Fischbach, Korinna Fritz, Antonia Gaus, Laura Gottschalk, Kai Daniel Grandt, Utah-Maria Henniges, Toni Herta, Dorothea Jasper, Jutta Keller, Nina Kschowak, Konstantin Lang, Alina Lange, Peter Layer, Niels Liedtke, Janek Luttermann, Lida Mancke, Viola Sophie Meier, Ulrike Melle, Daniela Menge, Stefan Michaelis, Sara Nader, Tim-Alexander Niedergassel, Carsten Pachmann, Rainer Porschen, Solveig Rose, Ulrich Rosien, Martin Rössle, Melina Schellhorn, Oliver Schnell, Sebastian Schulz, Julian Siegel, Alexander Stein, Johannes Szuba, Sarah Teising, Stephanie Thiel, Julia Thomas-Morr, Henriette Tillmann, Friederike Todt, Rhea Veelken, Henrike von Schassen, Michael Wölfel, Susanna Wolf, Valentin Wolgast, Clara Wübbolding & Kathrin Zimmermann. 2021. Facharztwissen Gastroenterologie und Hepatologie. Facharztwissen Gastroenterologie und Hepatologie
443
582
.
Yonatan Edel, Rivka Mamet, Sharon Cohen, Daniel Shepshelovich, Assi Levi & Iftach Sagy. (2020) The clinical importance of early acute hepatic porphyria diagnosis: a national cohort. Internal and Emergency Medicine 16:1, pages 133-139.
Crossref
Crossref
Luciana Amaral Haddad. 2021. Human Genome Structure, Function and Clinical Considerations. Human Genome Structure, Function and Clinical Considerations
93
138
.
Sebastian Nunnemann, Christoph Uibel, Petra Budig & Mathias Mäurer. (2020) Acute intermittent porphyria (AIP) in a patient with celiac disease. Neurological Research and Practice 2:1.
Crossref
Crossref
Carl Michael Baravelli, Aasne Karine Aarsand, Sverre Sandberg & Mette Christophersen Tollånes. (2020) Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study. Orphanet Journal of Rare Diseases 15:1.
Crossref
Crossref
Grace Swart, Su San Lim & Martin Jude. (2020) Acute intermittent porphyria presenting with posterior reversible encephalopathy syndrome (PRES) and abdominal pain. Practical Neurology 20:6, pages 486-488.
Crossref
Crossref
F.J. Castelbón Fernández, I. Solares Fernandez, E. Arranz Canales, R. Enríquez de Salamanca Lorente & M. Morales Conejo. (2020) Protocol for patients with suspected acute porphyria. Revista Clínica Española (English Edition) 220:9, pages 592-596.
Crossref
Crossref
F.J. Castelbón Fernández, I. Solares Fernandez, E. Arranz Canales, R. Enríquez de Salamanca Lorente & M. Morales Conejo. (2020) Protocolo de actuación en pacientes con sospecha de porfiria aguda. Revista Clínica Española 220:9, pages 592-596.
Crossref
Crossref
Mohamed Kazamel, Robert J. Desnick & John G. Quigley. (2020) Porphyric Neuropathy: Pathophysiology, Diagnosis, and Updated Management. Current Neurology and Neuroscience Reports 20:12.
Crossref
Crossref
Lanlan ZhaoXinyang WangXiaoning ZhangXiantao LiuNingzhen MaYiran ZhangSongyun Zhang. (2020) Therapeutic strategies for acute intermittent porphyria. Intractable & Rare Diseases Research 9:4, pages 205-216.
Crossref
Crossref
Fedor N. Novikov, Viktor S. Stroylov, Igor V. Svitanko & Vladimir E. Nebolsin. (2020) Molecular basis of COVID-19 pathogenesis. Russian Chemical Reviews 89:8, pages 858-878.
Crossref
Crossref
Anshita Aggarwal & Bindu Kulshreshtha. (2020) Catamenial Acute Intermittent Porphyria Managed with GnRH Analogues and Estrogen and Progesterone Add-back Therapy. Journal of Pediatric and Adolescent Gynecology 33:4, pages 432-434.
Crossref
Crossref
Aaron M. Cohen, Steven Chamberlin, Thomas Deloughery, Michelle Nguyen, Steven Bedrick, Stephen Meninger, John J. Ko, Jigar J. Amin, Alex J. Wei & William Hersh. (2020) Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria. PLOS ONE 15:7, pages e0235574.
Crossref
Crossref
Manisha BalwaniEliane SardhPaolo VenturaPaula Aguilera PeiróDavid C. ReesUlrich StölzelD. Montgomery BissellHerbert L. BonkovskyJerzy WindygaKarl E. AndersonCharles ParkerSamuel M. SilverSiobán B. KeelJiaan-Der WangPenelope E. SteinPauline HarperDaphne VassiliouBruce WangJohn PhillipsAneta IvanovaJanneke G. LangendonkRaili KauppinenElisabeth MinderYutaka HorieCraig PenzJihong ChenShangbin LiuJohn J. KoMarianne T. SweetserPushkal GargAkshay VaishnawJae B. KimAmy R. SimonLaurent Gouya. (2020) Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria. New England Journal of Medicine 382:24, pages 2289-2301.
Crossref
Crossref
Elena Di Pierro & Francesca Granata. (2020) Nutrients and Porphyria: An Intriguing Crosstalk. International Journal of Molecular Sciences 21:10, pages 3462.
Crossref
Crossref
Yang Yang, Xiyun Chen, Huijuan Wu, Hua Peng, Wenjing Sun, Bin He & Zhengang Yuan. (2020) A novel heterozygous mutation in the HMBS gene in a patient with acute intermittent porphyria and posterior reversible encephalopathy syndrome. Molecular Medicine Reports 22:1, pages 516-524.
Crossref
Crossref
K. Baumann & R. Kauppinen. (2020) Penetrance and predictive value of genetic screening in acute porphyria. Molecular Genetics and Metabolism 130:1, pages 87-99.
Crossref
Crossref
Enrique Esteve-Valverde, Alfonso Tapiz-Reula, Domingo Ruiz & Jaume Alijotas-Reig. (2019) Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria. Rheumatology International 40:5, pages 777-783.
Crossref
Crossref
Helene J. Bustad, Karen Toska, Caroline Schmitt, Marta Vorland, Lars Skjærven, Juha P. Kallio, Sylvie Simonin, Philippe Letteron, Jarl Underhaug, Sverre Sandberg & Aurora Martinez. (2020) A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria. Molecular Therapy 28:2, pages 677-689.
Crossref
Crossref
Pedro Renato de Paula Brandão, Simoneide S. Titze-de-Almeida & Ricardo Titze-de-Almeida. (2019) Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on Givosiran. Molecular Diagnosis & Therapy 24:1, pages 61-68.
Crossref
Crossref
Syeda Anum Fatima, Humaira Jurair, Qalab Abbas & Arshalooz Jamila Rehman. (2020) Paediatric porphyria and human hemin: a treatment challenge in a lower middle income country. BMJ Case Reports 13:1, pages e232236.
Crossref
Crossref
Elizabeth L. Frank & M. Laura Parnás. 2020. Contemporary Practice in Clinical Chemistry. Contemporary Practice in Clinical Chemistry
885
894
.
Yanying Guo, Jianwen Zhao, Hongmei Wang, Shanshan Liu, Tai Huang & Guijuan Chang. 2020. Secondary Hypertension. Secondary Hypertension
507
545
.
Diego Vera-Yunca, Irantzu Serrano-Mendioroz, Ana Sampedro, Daniel Jericó, Iñaki F. Trocóniz, Antonio Fontanellas & Zinnia P. Parra-Guillén. (2019) Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model. Molecular Genetics and Metabolism 128:3, pages 367-375.
Crossref
Crossref
Katell Peoc'h, Hana Manceau, Zoubida Karim, Staffan Wahlin, Laurent Gouya, Hervé Puy & Jean-Charles Deybach. (2019) Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword. Molecular Genetics and Metabolism 128:3, pages 236-241.
Crossref
Crossref
Carlos Dias Silva, José Eduardo Mateus, Carolina Teles & Teresa Vaio. (2019) Acute intermittent porphyria: analgesia can be dangerous. BMJ Case Reports 12:9, pages e231133.
Crossref
Crossref
Joana Rigor, Sara Almeida Pinto & Daniela Martins-Mendes. (2019) Porphyrias: A clinically based approach. European Journal of Internal Medicine 67, pages 24-29.
Crossref
Crossref
Grace R Williams & Robert D Nerenz. (2019) Not Your Ordinary Rash. Clinical Chemistry 65:6, pages 733-736.
Crossref
Crossref
Pradeep Yarra, Denise Faust, Mary Bennett, Sean Rudnick & Herbert L. Bonkovsky. (2019) Benefits of prophylactic heme therapy in severe acute intermittent porphyria. Molecular Genetics and Metabolism Reports 19, pages 100450.
Crossref
Crossref
Gabriela S. Gheorghe, Andreea S. Hodorogea, Andrei C. D. Gheorghe, Ondin I. R. Zaharia, Ovidiu Neacsu, Ioan Tiberiu Nanea & Ana Ciobanu. (2019) Particular etiology in a case of peripheral tetraparesis. Clinical Case Reports 7:5, pages 1062-1066.
Crossref
Crossref
Laura M. Huckins, Amanda Dobbyn, Douglas M. Ruderfer, Gabriel Hoffman, Weiqing Wang, Antonio F. Pardiñas, Veera M. Rajagopal, Thomas D. Als, Hoang T. Nguyen, Kiran Girdhar, James Boocock, Panos Roussos, Menachem Fromer, Robin Kramer, Enrico Domenici, Eric R. Gamazon, Shaun Purcell, Ditte Demontis, Anders D. Børglum, James T. R. Walters, Michael C. O’Donovan, Patrick Sullivan, Michael J. Owen, Bernie Devlin, Solveig K. Sieberts, Nancy J. Cox, Hae Kyung Im, Pamela Sklar & Eli A. Stahl. (2019) Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nature Genetics 51:4, pages 659-674.
Crossref
Crossref
Eliane SardhPauline HarperManisha BalwaniPenelope SteinDavid ReesD. Montgomery BissellRobert DesnickCharles ParkerJohn PhillipsHerbert L. BonkovskyDaphne VassiliouCraig PenzAmy Chan-DanielsQiuling HeWilliam QuerbesKevin FitzgeraldJae B. KimPushkal GargAkshay VaishnawAmy R. SimonKarl E. Anderson. (2019) Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria. New England Journal of Medicine 380:6, pages 549-558.
Crossref
Crossref
Oscar J. Wambuguh. 2019. Examining the Causal Relationship Between Genes, Epigenetics, and Human Health. Examining the Causal Relationship Between Genes, Epigenetics, and Human Health
288
324
.
S. A. Andreychenko, T. A. Sukonnikov, M. V. Bychinin & T. V. Klypa. (2019) Difficulties in the diagnosis of acute porphyria: case report. Anesteziologiya i Reanimatologiya:3, pages 90.
Crossref
Crossref
Masaki Iwai, Atsushi Kitamura, Hajime Isomoto, Yutaka Horie & Wilson M. S. Tsui. 2019. Diagnosis of Liver Disease. Diagnosis of Liver Disease
151
171
.
Venuja Sriretnakumar, Ricardo Harripaul, John B. Vincent, James L. Kennedy & Joyce So. (2018) Enrichment of pathogenic variants in genes associated with inborn errors of metabolism in psychiatric populations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.
Crossref
Crossref
Elizabeth B. Malinzak, Nancy W. Knudsen, Ankeet D. Udani, Deepak Vikraman, Debra L. Sudan & Timothy E. Miller. (2018) Perioperative Challenges in Liver Transplantation for a Patient With Acute Intermittent Porphyria. Journal of Cardiothoracic and Vascular Anesthesia 32:6, pages 2716-2720.
Crossref
Crossref
Rolf Teschke. (2018) Aliphatic Halogenated Hydrocarbons: Report and Analysis of Liver Injury in 60 Patients. Journal of Clinical and Translational Hepatology.
Crossref
Crossref
Deborah Chiabrando, Veronica Fiorito, Sara Petrillo & Emanuela Tolosano. (2018) Unraveling the Role of Heme in Neurodegeneration. Frontiers in Neuroscience 12.
Crossref
Crossref
Ronan O’Malley, Ganesh Rao, Penelope Stein & Oliver Bandmann. (2018) Porphyria: often discussed but too often missed. Practical Neurology 18:5, pages 352-358.
Crossref
Crossref
Amy Simon, Farrah Pompilus, William Querbes, Alex Wei, Sara Strzok, Craig Penz, Desiree Lyon Howe, Jessica R. Hungate, Jae B. Kim, Sonalee Agarwal & Patrick Marquis. (2018) Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations. The Patient - Patient-Centered Outcomes Research 11:5, pages 527-537.
Crossref
Crossref
Isabella Tabaro, Giuseppe Reimondo, Giangiacomo Osella, Caterina Aurizi, Pasquale Caraci, Luca Barbieri, Daniela Francesca Giachino, Fabio Sirchia & Massimo Terzolo. (2018) Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. Endocrine 61:3, pages 403-406.
Crossref
Crossref
P. Martin. (2018) Schmerz und EpilepsiePain and epilepsy. Der Schmerz 32:4, pages 301-320.
Crossref
Crossref
C. Schmitt, H. Lenglet, A. Yu, C. Delaby, A. Benecke, T. Lefebvre, P. Letteron, V. Paradis, S. Wahlin, S. Sandberg, P. Harper, E. Sardh, A. K. Sandvik, J. R. Hov, A. K. Aarsand, L. Chiche, C. Bazille, J.-Y. Scoazec, J. To-Figueras, M. Carrascal, J. Abian, A. Mirmiran, Z. Karim, J.-C. Deybach, H. Puy, K. Peoc'h, H. Manceau & L. Gouya. (2018) Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver. Journal of Internal Medicine 284:1, pages 78-91.
Crossref
Crossref
Sebastian Nunnemann. (2018) Enzymdefekt mit schweren Folgen. DNP - Der Neurologe & Psychiater 19:3, pages 26-30.
Crossref
Crossref
Mark H. CordenJamie Frediani, Frank XuQuin Y. Liu, Shiu-Yi Emily ChenD. Montgomery Bissell & Kathleen Ostrom. (2018) An 18-Year-Old With Acute-on-Chronic Abdominal Pain. Pediatrics 141:5.
Crossref
Crossref
Rolf Teschke. (2018) Liver Injury by Carbon Tetrachloride Intoxication in 16 Patients Treated with Forced Ventilation to Accelerate Toxin Removal via the Lungs: A Clinical Report. Toxics 6:2, pages 25.
Crossref
Crossref
Areeba Kara, Somnath Mookherjee, Warren Gavin & Karen McDonough. (2017) Off Target But Hitting the Mark. Journal of Hospital Medicine 13:4, pages 280-284.
Crossref
Crossref
Grace Hunter, Rebecca Blankenburg, Jennifer Andrews & Terrell Stevenson. (2018) An Unusual Case of Abdominal Pain and Hyponatremia in a 16-Year-Old Girl With Disordered Eating. Pediatrics 141:1.
Crossref
Crossref
. 2018. Facharzt Gastroenterologie. Facharzt Gastroenterologie
321
451
.
M. Kowar & A. H. Jacobs. (2017) Wechselnde Vigilanz und Fremdaggressivität bei einer 89‑jährigen PatientinAltered orientation and aggressiveness in an 89-year-old woman. Der Internist 59:1, pages 97-101.
Crossref
Crossref
Satish V. Khadilkar, Rakhil S. Yadav & Bhagyadhan A. PatelSatish V. Khadilkar, Rakhil S. Yadav & Bhagyadhan A. Patel. 2018. Neuromuscular Disorders. Neuromuscular Disorders
493
502
.
Jorge Vidaurre, Satyanarayana Gedela & Shannon Yarosz. (2017) Antiepileptic Drugs and Liver Disease. Pediatric Neurology 77, pages 23-36.
Crossref
Crossref
José Julián Mejia B, Dayana Caballero, Jaime Villanueva & Carmelo Rafael Dueñas Castell. (2017) Porfirias agudas: enfoque diagnóstico y terapéutico. Acta Colombiana de Cuidado Intensivo 17:4, pages 276-294.
Crossref
Crossref
Ivan Žebeljan, Veronika Anzeljc, Tamara Serdinšek & Faris Mujezinović. (2017) A case of previously undiagnosed acute intermittent porphyria in a 34-year-old primigravida with gestational diabetes mellitus. Case Reports in Perinatal Medicine 6:2.
Crossref
Crossref
Van Leung-Pineda & Don P Wilson. (2017) Severe Abdominal Pain with Hyponatremia. Clinical Chemistry 63:9, pages 1544-1545.
Crossref
Crossref
Alex Gomez-Gomez, Josep Marcos, Paula Aguilera, Jordi To-Figueras & Oscar J Pozo. (2017) Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria. Journal of Chromatography B 1060, pages 347-354.
Crossref
Crossref
Shirin AttarianChunli Yu, Karl E. Anderson & Ellen W. Friedman. (2017) Effects of hemin and hemodialysis in a patient with acute intermittent porphyria and renal failure. Blood Advances 1:14, pages 915-917.
Crossref
Crossref
Teminioluwa Ajayi, Rachael Ward, Bryant Summers, Jennifer Byrns, Matthew Kappus, Steve Choi & Julius Wilder. (2017) Pathophysiology, Pharmacology and Treatment of Acute Intermittent Porphyria: A Patient Case Description and Recommendations from the Current Literature. Journal of Exploratory Research in Pharmacology 2:2, pages 49-53.
Crossref
Crossref
V. R. Souza Júnior, V. M. V. Lemos, I. M. L. Feitosa, R. Florencio, C. W. B. Correia, L. B. Correia Fontes, M. F. Hazin Costa & M. C. B. Correia. (2017) Effect of Menstrual Cycle on Acute Intermittent Porphyria. Child Neurology Open 4, pages 2329048X1773617.
Crossref
Crossref
Chengjung Lai, Cristina Martin-Higueras & Eduardo Salido. 2017. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders. Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders
159
190
.
Tim Smeets & Florence van Hunsel. (2016) Red-Brown Urine Discolouration in Two Patients Taking Mesalamine. Drug Safety - Case Reports 3:1.
Crossref
Crossref
Hetanshi Naik, Mikayla Stoecker, Saskia C. Sanderson, Manisha Balwani & Robert J. Desnick. (2016) Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study. Molecular Genetics and Metabolism 119:3, pages 278-283.
Crossref
Crossref
Joel Norton, Christine Hymers, Penelope Stein, Joanne May Jenkins & Duncan Bew. (2016) Acute Porphyria Presenting as Major Trauma: Case Report and Literature Review. The Journal of Emergency Medicine 51:5, pages e115-e122.
Crossref
Crossref
Sumant Arora, Steven Young, Sudha Kodali & Ashwani K. Singal. (2016) Hepatic porphyria: A narrative review. Indian Journal of Gastroenterology 35:6, pages 405-418.
Crossref
Crossref
María Collantes, Irantzu Serrano-Mendioroz, Marina Benito, Francisco Molinet-Dronda, Mercedes Delgado, María Vinaixa, Ana Sampedro, Rafael Enríquez de Salamanca, Elena Prieto, Miguel A. Pozo, Iván Peñuelas, Fernando J. Corrales, Miguel Barajas & Antonio Fontanellas. (2016) Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency. Human Molecular Genetics 25:7, pages 1318-1327.
Crossref
Crossref
José Salvador García-Morillo, Aurora González-Estrada & Santiago Rodriguez-Suarez. (2016) Efecto a largo plazo de las infusiones de hematina en el desarrollo de enfermedad renal crónica en la porfiria aguda intermitente. Medicina Clínica 146:8, pages 373-374.
Crossref
Crossref
José Salvador García-Morillo, Aurora González-Estrada & Santiago Rodriguez-Suarez. (2016) Influence of long-term treatment with hemin in the development of chronic renal failure in acute intermittent porphyria. Medicina Clínica (English Edition) 146:8, pages 373-374.
Crossref
Crossref
V. Kürten, N. J. Neumann & J. Frank. (2016) Diagnostik der PorphyrienDiagnosis of the porphyrias. Der Hautarzt 67:3, pages 201-206.
Crossref
Crossref